In the present study, our data suggest that UC-MSCs inhibited the proliferation of CD4+T cells and immunosuppressed the production of IL-22 in ITP patients through soluble cellular factors. This evidence concerns the gene IL22 and autoimmune thrombocytopenic purpura.